MORRISVILLE, N.C., Oct. 2, 2018 /PRNewswire/ -- Pyxus
International Inc. (NYSE: PYX) is pleased to announce that its
indirect Canadian subsidiary, Goldleaf Pharm Inc., has received its
Access to Cannabis for Medical Purposes Regulations (ACMPR)
cultivation license from Health Canada. The license, awarded
September 28, 2018, permits Goldleaf
Pharm to begin cultivating medicinal cannabis at its Simcoe, Ontario facility.
"This is an important step, and an exciting time, for us at
Goldleaf Pharm," said Larry Huszczo,
Goldleaf Pharm's co-founder. "We have a state of the art 20,000
square foot indoor growing facility, and recently acquired 20-acres
of adjacent property, giving us the ability to expand to more than
700,000 square feet of production space to cultivate cannabis. I am
very proud of our team, which has worked diligently to meet Health
Canada's requirements."
Goldleaf Pharm is a subsidiary of Pyxus' indirect Canadian
subsidiary, FIGR Inc. This latest milestone follows shortly after
an announcement by FIGR that its Charlottetown subsidiary, Canada's Island
Garden Inc. (CIG), received approval from Health Canada for the
sale of medicinal cannabis oils. CIG previously announced a supply
agreement with the province of Prince
Edward Island for 1,000 kilograms/kilogram equivalent of
cannabis products.
With this development, FIGR's two subsidiaries are now both
licensed to produce medicinal cannabis in Canada. This also places FIGR's subsidiaries
in a position to produce cannabis for adult recreational use in
Canada after October 17, 2018, when it is set to become legal
in that country.
About Pyxus International, Inc.
Pyxus International
Inc. is a global agricultural company with 145 years' experience
delivering value-added products and services to businesses and
customers. Driven by a united purpose—to transform people's lives,
so that together we can grow a better world—Pyxus International,
its subsidiaries and affiliates, are trusted providers of
responsibly sourced, independently verified, sustainable and
traceable products and ingredients. For more information, visit
www.pyxusintl.com.
View original
content:http://www.prnewswire.com/news-releases/pyxus-indirect-canadian-subsidiary-receives-acmpr-cannabis-cultivation-license-from-health-canada-300722515.html
SOURCE Pyxus International, Inc.